Form 4: REGENXBIO Chief Legal Officer Patrick J. Christmas Reports Stock Transaction
SEC Form 4
Patrick J. Christmas, Chief Legal Officer of REGENXBIO Inc., reports the withholding of 4,700 shares of common stock to cover taxes upon vesting of restricted stock units on February 1, 2025.
Summary
- On April 4, 2025, Patrick J. Christmas, the Chief Legal Officer of REGENXBIO Inc. (RGNX), filed a Form 4.
- The report details a transaction on February 1, 2025, where 4,700 shares of common stock were withheld to cover taxes related to the vesting of restricted stock units.
- The shares were withheld at a price of $8.07 per share.
- Following the transaction, Christmas directly owns 156,110 shares of REGENXBIO common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of restricted stock units and the subsequent withholding of shares to cover tax obligations, a common practice in executive compensation.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date of original grant of restricted stock units to the reporting person. |
| 02/01/2025 | Date of transaction: shares of common stock withheld to pay taxes upon vesting of restricted stock units. |
| 04/04/2025 | Date of Form 4 filing. |
Keywords
Form 4, REGENXBIO, RGNX, Patrick J. Christmas, Chief Legal Officer, Stock Transaction, Beneficial Ownership, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.